Expression of Bacillus anthracis Protective Antigen in Bacillus megaterium

Abstract

Bacillus anthracis protective antigen is the central component of the anthrax toxin complexes that facilitates entry of lethal factor and edema factor into host cells. Protective antigen is also the major immunogenic component present in the currently licensed anthrax vaccine. In order to produce full-length, soluble protective antigen, the gene has been cloned and expressed using Bacillus megaterium and a xylose-inducible heterologous expression system. After only 3.5 hours growth post-induction in Luria-Bertani broth, the transgenic B. megaterium were found to secrete approximately 1 mug/ml protective antigen into the culture medium. The recombinant protein was easily purified to homogeneity in a single step by ion exchange chromatography. N-terminal amino acid sequencing of the final product confirmed that the recombinant protective antigen was full-length and that no proteolytic degradation had occurred.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Mar 01, 2004
Accession Number
ADA472913

Entities

People

  • B. J. Berger
  • C. L. Radford
  • K. E. Schwandt

Tags

Communities of Interest

  • Air Platforms
  • Biomedical

DTIC Thesaurus Topics

  • Amino Acids
  • Anti-Bacterial Agents
  • Chemistry
  • Classification
  • Degradation
  • Escherichia Coli
  • Gel Electrophoresis
  • Ion Exchange
  • Materials
  • Microbiology
  • National Security
  • Protein Sequence Analysis
  • Proteins
  • Recombinant Proteins
  • Security
  • Sugar Alcohols
  • Vaccines

Fields of Study

  • Biology
  • Engineering

Readers

  • Immunology
  • Microbial Pathology
  • Molecular Genetics

Technology Areas

  • Biotechnology